Stock Taper
| DATE | TYPE | RATIO |
|---|---|---|
| 2026-01-08 | Reverse | 19:20 |
| 2025-01-29 | Reverse | 35:36 |
| 2024-01-30 | Reverse | 97:100 |
| 2017-01-25 | Reverse | 481:500 |
| 2000-07-14 | Forward | 4:1 |
| 1999-07-16 | Forward | 2:1 |
QIAGEN N.V. provides sample-to-insight molecular testing solutions, including consumables, instruments, assays, and bioinformatics for diagnostics, research, and pharma worldwide.

The QIAcuity is an automated digital PCR system by Qiagen that offers rapid, precise nucleic acid quantification in under two hours, streamlining mutation detection, gene expression, and copy number analysis.
| Icon | PRODUCT | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
![]() | Consumables and Related | — | — | — | $1.88B |
![]() | Diagnostic Solutions | $660.88M | $697.63M ▲ | $748.89M ▲ | $803.08M ▲ |
![]() | Sample Technologies | $796.93M | $662.99M ▼ | $642.03M ▼ | $661.26M ▲ |
![]() | PCR Nucleic Acid Amplification | $390.8M | $300.2M ▼ | $300.47M ▲ | $308.99M ▲ |
![]() | Genomics NGS | $224.8M | $238.91M ▲ | $233.61M ▼ | $241.78M ▲ |
![]() | Instruments | — | — | — | $213.57M |
![]() | Product and Service Other | $68.11M | $65.58M ▼ | $53.22M ▼ | $74.89M ▲ |
| Map | REGION | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
![]() | Total Americas | $997.75M | $1.02B ▲ | $1.03B ▲ | $1.09B ▲ |
![]() | UNITED STATES | — | — | — | $998.45M |
![]() | EMEA | $733.47M | $624.57M ▼ | $648.49M ▲ | $712.76M ▲ |
![]() | Asia Pacific and Rest of World | $410.29M | $320.68M ▼ | $298.15M ▼ | $290.73M ▼ |
![]() | Other Americas | — | — | — | $88.06M |
Overall rating: A-
| PEER | PRICE | |
|---|---|---|
RVTY | $128.80 | COMPARE |
CRL | $291.50 | COMPARE |
EXEL | $54.45 | COMPARE |
BAX | $26.13 | COMPARE |
ICLR | $170.02 | COMPARE |
BMRN | $64.67 | COMPARE |
TECH | $72.35 | COMPARE |
ALGN | $157.58 | COMPARE |